TDOC
Undervalued by 225.5% based on the discounted cash flow analysis.
Market cap | $2.20 Billion |
---|---|
Enterprise Value | $2.64 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-1.41 |
Beta | 2.01 |
Outstanding Shares | 169,588,171 |
Avg 30 Day Volume | 5,265,573 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -9.45 |
---|---|
PEG | -51.69 |
Price to Sales | 0.87 |
Price to Book Ratio | 1.0 |
Enterprise Value to Revenue | 1.01 |
Enterprise Value to EBIT | -11.78 |
Enterprise Value to Net Income | -12 |
Total Debt to Enterprise | 0.58 |
Debt to Equity | 0.67 |
No data
No data
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized int...